Heading into the user fee reauthorization cycle, it seems inevitable that some form of federal 'right to try' legislation will tag-along for the ride. The recently departed head of the Office of New Drugs is among those who thinks the innocuous-sounding bill is a very bad idea.
Heading into the user fee reauthorization cycle, there appears to be almost no way to prevent inclusion of some version of federal “right to try” legislation.
The most likely add on is a bill, known as “Trickett-Wendler Right to Try Act”, which would direct...